Matthew Hawryluk Gritstone Bio, Inc. (GRTS) insider trading activity

Matthew Hawryluk is EVP, CHIEF BUSINESS OFFICER of Gritstone bio, Inc.. Currently has a direct ownership of 313,931 shares of GRTS, which is worth approximately $9,417. The most recent transaction as insider was on May 16, 2024, when has been sold 9,259 shares (Common Stock) at a price of $0.75 per share, resulting in proceeds of $6,944. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 314K

0% 3M change

26.43% 12M change

Total Value Held $9,417

Matthew Hawryluk Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2024	SELL Open market or private sale	$6,944 $0.75 p/Share	9,259 Reduced 2.86%	313,931 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	-	19,149 Added 5.59%	323,190 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	35,000 Added 10.87%	286,880 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	191,771 Added 43.58%	248,311 Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	-	21,612 Added 28.83%	53,351 Common Stock
Jan 07 2021	BUY Grant, award, or other acquisition	-	19,600 Added 44.75%	24,198 Common Stock

Also insider at

POAI

Predictive Oncology Inc. Healthcare

Director